SI1963355T1 - Novi derivati holest-4-en-3-on oksima, farmacevtski sestavki, ki jih vsebujejo, in postopek za pripravo - Google Patents

Novi derivati holest-4-en-3-on oksima, farmacevtski sestavki, ki jih vsebujejo, in postopek za pripravo

Info

Publication number
SI1963355T1
SI1963355T1 SI200630520T SI200630520T SI1963355T1 SI 1963355 T1 SI1963355 T1 SI 1963355T1 SI 200630520 T SI200630520 T SI 200630520T SI 200630520 T SI200630520 T SI 200630520T SI 1963355 T1 SI1963355 T1 SI 1963355T1
Authority
SI
Slovenia
Prior art keywords
new
oxime derivatives
cholesten
cholest
pharmaceutical compositions
Prior art date
Application number
SI200630520T
Other languages
English (en)
Inventor
Cyrille Drouot
Delphine Maux
Original Assignee
Trophos Parc Scient Luminy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos Parc Scient Luminy filed Critical Trophos Parc Scient Luminy
Publication of SI1963355T1 publication Critical patent/SI1963355T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SI200630520T 2005-12-20 2006-12-15 Novi derivati holest-4-en-3-on oksima, farmacevtski sestavki, ki jih vsebujejo, in postopek za pripravo SI1963355T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512947A FR2894968B1 (fr) 2005-12-20 2005-12-20 Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
EP06841943A EP1963355B1 (fr) 2005-12-20 2006-12-15 Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation

Publications (1)

Publication Number Publication Date
SI1963355T1 true SI1963355T1 (sl) 2010-02-26

Family

ID=37054406

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630520T SI1963355T1 (sl) 2005-12-20 2006-12-15 Novi derivati holest-4-en-3-on oksima, farmacevtski sestavki, ki jih vsebujejo, in postopek za pripravo

Country Status (17)

Country Link
US (3) US8481515B2 (sl)
EP (1) EP1963355B1 (sl)
JP (1) JP5452932B2 (sl)
AT (1) ATE444302T1 (sl)
AU (1) AU2006334608B2 (sl)
BR (1) BRPI0620133A2 (sl)
CA (1) CA2633633C (sl)
CY (1) CY1110592T1 (sl)
DE (1) DE602006009557D1 (sl)
DK (1) DK1963355T3 (sl)
ES (1) ES2331755T3 (sl)
FR (1) FR2894968B1 (sl)
IL (1) IL192258A (sl)
PL (1) PL1963355T3 (sl)
PT (1) PT1963355E (sl)
SI (1) SI1963355T1 (sl)
WO (1) WO2007080270A2 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
FR2894968B1 (fr) * 2005-12-20 2008-02-22 Trophos Sa Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
FR2919180B1 (fr) * 2007-07-25 2009-11-27 Trophos Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
AU2008348717B2 (en) * 2007-10-30 2013-09-19 Trophos Novel composition for treating the side effects of anticancer treatments
FR2934596B1 (fr) * 2008-07-30 2015-04-10 Trophos Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
WO2012069150A2 (en) 2010-11-22 2012-05-31 Powerpore Gmbh Cytoprotectant agents for the prevention of drug-associated side-effects
FR2979239A1 (fr) 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol
TWI648273B (zh) 2013-02-15 2019-01-21 英商葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之雜環醯胺類（三）
CN115040524A (zh) * 2022-07-27 2022-09-13 深圳市中西医结合医院 4-胆甾烯-3-酮用于治疗多发性骨髓瘤骨病的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2401934A1 (fr) * 1977-08-31 1979-03-30 Roussel Uclaf Nouveau procede de preparation d'oximes en 3 de derives steroides
JPH06172378A (ja) * 1992-12-03 1994-06-21 Taisho Pharmaceut Co Ltd ステロイド化合物
ES2190348B1 (es) * 2001-07-19 2005-02-01 Universidade Da Coruña Nuevos 6e-hidroximinoesteroides: su procdimiento de obtencion mediantesintesis a partir de esteroides comerciales, y su aplicacion como agentes citotoxicos.
JP4970932B2 (ja) * 2003-03-11 2012-07-11 トロフォ コレスト−４−エン−３−オンの誘導体の医薬としての使用、これらを含む医薬組成物、新規誘導体及びそれらの製造方法
FR2852246B1 (fr) * 2003-03-11 2005-07-08 Utilisation de l'oxime de cholest-4-en-3-one dans le traitement des affections du motoneurone
FR2860159B1 (fr) * 2003-09-26 2005-12-02 Trophos Utilisation de l'oxime de cholest-4-en-3-one en tant que medicament neuroprotecteur
CN1450080A (zh) * 2003-05-22 2003-10-22 中国科学院广州化学研究所 一种新的甾体化合物及其提取方法
FR2894968B1 (fr) * 2005-12-20 2008-02-22 Trophos Sa Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation

Also Published As

Publication number Publication date
ES2331755T3 (es) 2010-01-14
WO2007080270A3 (fr) 2007-09-20
US20150225443A1 (en) 2015-08-13
US8481515B2 (en) 2013-07-09
US20090203662A1 (en) 2009-08-13
PT1963355E (pt) 2009-11-19
AU2006334608A1 (en) 2007-07-19
CA2633633C (fr) 2015-11-17
EP1963355B1 (fr) 2009-09-30
WO2007080270A2 (fr) 2007-07-19
CA2633633A1 (fr) 2007-07-19
JP2009520006A (ja) 2009-05-21
PL1963355T3 (pl) 2010-03-31
IL192258A0 (en) 2008-12-29
DK1963355T3 (da) 2009-12-14
DE602006009557D1 (de) 2009-11-12
EP1963355A2 (fr) 2008-09-03
BRPI0620133A2 (pt) 2011-11-01
US20120122827A1 (en) 2012-05-17
CY1110592T1 (el) 2015-04-29
JP5452932B2 (ja) 2014-03-26
FR2894968B1 (fr) 2008-02-22
FR2894968A1 (fr) 2007-06-22
AU2006334608B2 (en) 2012-05-03
ATE444302T1 (de) 2009-10-15
IL192258A (en) 2013-01-31

Similar Documents

Publication Publication Date Title
PL1963355T3 (pl) Nowe pochodne oksymu cholest-4-en-3-onu, kompozycje farmaceutyczne zawierające te pochodne i sposób ich wytwarzania
HUS2100016I1 (hu) Piridiletilbenzamid-származékot és az ergoszterin bioszintézisét gátló képes vegyületet tartalmazó fungicid készítmény
ATE264337T1 (de) Glucopyranosyloxypyrazol-derivate, diese enthaltende arzneimittel und zwischenprodukte zu deren herstellung
BRPI0509258A (pt) composto de 8-oxoadenina 9-substituìda
CA2665931C (en) Hydrobenzamide derivatives as inhibitors of hsp90
WO2008140099A1 (ja) テトラゾイルオキシム誘導体および植物病害防除剤
NO20081125L (no) Antitumor middel
WO2009064374A3 (en) Oral formulations of bis(thiohydrazide amides)
CA2336412A1 (en) Medicament for treatment of diabetes
WO2006078724A3 (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
WO2009014105A1 (ja) 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
BRPI0413758A (pt) compostos para o tratamento de transtornos metabólicos
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
TW200720234A (en) Hydroxynaphthalenedicarboxylic acid hydrazide and derivatives thereof as well as process for preparing them
WO2009107853A3 (en) Agent for preventing or ameliorating skin aging
MX2007003468A (es) Formulaciones medicinales en aerosol y metodos de sintesis de los ingredientes para las mismas.
NL2027866B1 (en) Inhibitors of Nicotinamide N-methyl Transferase (NNMT)
PT1493441E (pt) Agente terapêutico para a desordem de competência alimentar no estômago
PL1631574T3 (pl) Analogi kolchikozydowe
WO2009022066A3 (fr) Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP1632495A3 (de) Methyllithium/Lithiumbromid enthaltendes Synthesemittel und Verfahren zu dessen Herstellung
CA2511750A1 (en) Dibenzodiazepinone analogues, processes for their production and their use as pharmaceuticals
WO2004016580A3 (fr) Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
FR2776658B3 (fr) Derives de methyl-biphenyle, leur procede de preparation et leur utilisation